Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Best Buy Co Inc (BBY) Price & Performance

AbCellera Biologics IncTrade
Best Buy Co IncTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Best Buy Co Inc — how do they compare? AbCellera Biologics Inc trades at $9.03 (market cap $2.99B), while Best Buy Co Inc trades at $83.5 (market cap $17.55B). The key difference: Best Buy Co Inc is far larger — about 5.9× AbCellera Biologics Inc's market cap, and Best Buy Co Inc pays a 4.61% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLBBY
Market Cap
$2.99B$17.55B
Sector
HealthConsumer Cyclical
52-Week High
$9.76$90.17
52-Week Low
$2.78$55.52
Enterprise Value
$2.58B$19.93B
Dividend Yield
4.61%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Best Buy Co Inc

With $51.8 billion in fiscal 2022 sales, Best Buy is the largest pure-play consumer electronics retailer in the U.S., with roughly 10.6% share of the aggregate market and north of 40% share of offline sales, per our calculations, CTA industry, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the COVID-19 pandemic, have seen the U.S. e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.

Read more on BBY